Cargando…

Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis

The magnitude of the immune response is closely associated with clinical outcome in patients with cancer. However, finding potential therapeutic targets for lung cancer in the immune system remains challenging. Here, we constructed a vital immune‐prognosis genes (VIPGs) based cluster of lung adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Fang‐lu, Xu, Zhan‐yu, Yuan, Li‐qiang, Chen, Wen‐jie, Wei, Jiang‐bo, Sun, Yu, Li, Shi‐kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459417/ https://www.ncbi.nlm.nih.gov/pubmed/32686362 http://dx.doi.org/10.1002/2211-5463.12934

Ejemplares similares

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
por: Liu, Le-Ping, et al.
Publicado: (2021)

Bioinformatics analyses for the identification of tumor antigens and immune subtypes of gastric adenocarcinoma
por: Wei, Shuxun, et al.
Publicado: (2022)

Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis
por: Yang, Fei-Ran, et al.
Publicado: (2022)

Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state
por: Huang, Jianbing, et al.
Publicado: (2020)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
por: Xu, Feng, et al.
Publicado: (2020)

Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy
por: Lu, Kunna, et al.
Publicado: (2022)

Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma
por: Zhang, Jinguo, et al.
Publicado: (2022)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma
por: Liu, Zi-Tao, et al.
Publicado: (2023)

Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes
por: Yu, Ruilin, et al.
Publicado: (2023)

ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis
por: Chen, Binyu, et al.
Publicado: (2023)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Identifying breast cancer subtypes associated modules and biomarkers by integrated bioinformatics analysis
por: Wang, Yanwei, et al.
Publicado: (2021)

Multi-Omics Analysis Elucidates The Immune And Intratumor Microbes Characteristics Of Ubiquitination Subtypes In Lung Adenocarcinoma
por: Wang, Siqi, et al.
Publicado: (2023)

Identification of molecular subtypes in lung adenocarcinoma based on DNA methylation and gene expression profiling—a bioinformatic analysis
por: Wang, Shuying, et al.
Publicado: (2022)

Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma
por: Zhou, Jian, et al.
Publicado: (2022)

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
por: Guo, Tingting, et al.
Publicado: (2019)

Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes
por: He, Jie, et al.
Publicado: (2020)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma
por: Xiang, Chan, et al.
Publicado: (2022)

Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes
por: Liu, Qi, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
por: Xu, Zhan-yu, et al.
Publicado: (2020)

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas
por: Tlemsani, Camille, et al.
Publicado: (2019)

Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data
por: Sun, Fenghao, et al.
Publicado: (2017)

Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications
por: Wen, Heng, et al.
Publicado: (2022)

Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis
por: Li, Jie, et al.
Publicado: (2020)

Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
por: Yang, Xiaodong, et al.
Publicado: (2022)

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma
por: Huo, Ji-wen, et al.
Publicado: (2022)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma
por: Li, Yamei, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma
por: Pan, Meini, et al.
Publicado: (2023)

Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
por: Liu, Chia-Hsin, et al.
Publicado: (2022)

Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer
por: Cao, Jing, et al.
Publicado: (2021)

Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma
por: Wang, Liqiang, et al.
Publicado: (2022)

Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma
por: Guo, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n65gqnmhnfa7ce98p0tteth7mg